Zobrazeno 1 - 10
of 29
pro vyhledávání: '"EN Kornaga"'
Autor:
Kathy Gratton, NA Nixon, Gloria B. Roldán Urgoiti, Zhong Qiao Shi, Ailian Yang, Don Morris, EN Kornaga
Publikováno v:
Cancer Research. 80:P3-06
Approximately 15% of newly diagnosed breast cancers (BC) are classified as triple negative (TNBC), which have a worse prognosis than hormonal receptor-positive BCs. Standard treatment for TNBC includes cytotoxic chemotherapies that are associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acdd4703a998d6ba75cb7e8ced077644
https://doi.org/10.1158/1538-7445.sabcs19-p3-06-10
https://doi.org/10.1158/1538-7445.sabcs19-p3-06-10
Publikováno v:
Cancer Research. 79:P2-08
Background: Access to cancer screening, diagnosis and treatment in the United States (US) is affected by insurance status; whereas, access within a publicly-funded health care system is similar across the whole population. The aim of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5e1400798a8e3c5dd5f6996e4e5387c
https://doi.org/10.1158/1538-7445.sabcs18-p2-08-13
https://doi.org/10.1158/1538-7445.sabcs18-p2-08-13
Publikováno v:
Cancer Research. 78:P3-07
BACKGROUND: Approximately 15% of newly diagnosed breast cancers are classified as triple negative (TNBC). TNBCs are considered more aggressive and have a worse prognosis as no targeted therapies are currently available. These tumors are routinely tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fee1b8cbeb69eadc4c82ecf2d940cd6
https://doi.org/10.1158/1538-7445.sabcs17-p3-07-08
https://doi.org/10.1158/1538-7445.sabcs17-p3-07-08
Autor:
Xiaolan Feng, Anthony M. Magliocco, Ahg Paterson, Alexander C. Klimowicz, Don Morris, EN Kornaga
Publikováno v:
Cancer Research. 77:P6-09
Introduction: Hormone receptors ER and PgR are routinely assessed by pathologists using immunohistochemical (IHC) assays to guide treatment decisions. Patients who are hormone receptor positive are offered hormonal therapy, such as tamoxifen, which i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d943d37cdeadaddb8c1b79c3405fb32
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-20
https://doi.org/10.1158/1538-7445.sabcs16-p6-09-20
Autor:
Tasnima Abedin, C.M. Doll, John B. McIntyre, Prafull Ghatage, Tien Phan, Susan P. Lees-Miller, Kevin Martell, EN Kornaga, Angela Chan, M. Koebel
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:e454
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a3151228ef115c16e7d31da06c21148
https://doi.org/10.1016/j.ijrobp.2020.07.2564
https://doi.org/10.1016/j.ijrobp.2020.07.2564
Autor:
John B. McIntyre, Alexander C. Klimowicz, Natalia Guggisberg, Anthony M. Magliocco, Don Morris, EN Kornaga
Publikováno v:
Cancer Research. 75:P5-10
*Co-First Authors Background: Currently, patients diagnosed with breast carcinoma undergo HER2 testing to direct clinical treatment decisions. At present, immunohistochemical (IHC) and in-situ hybridization methodologies are employed in the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ed7de520f83c6b560239ae0b747117
https://doi.org/10.1158/1538-7445.sabcs14-p5-10-16
https://doi.org/10.1158/1538-7445.sabcs14-p5-10-16
Autor:
Xiaolan Feng, Alexander C. Klimowicz, Don Morris, EN Kornaga, N Guggisberg, Michelle Dean, Anthony M. Magliocco
Publikováno v:
Cancer Research. 76:P5-07
BACKGROUND: Presently, therapy for treatment of breast cancer is based on the evaluation of formalin fixed, paraffin embedded (FFPE) pathological specimens using a combination of immunohistochemistry (IHC) and gene copy assessment by in-situ hybridiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::050a5cb84a8cda82ebb8753e2ac57c53
https://doi.org/10.1158/1538-7445.sabcs15-p5-07-07
https://doi.org/10.1158/1538-7445.sabcs15-p5-07-07
Autor:
N Guggisberg, Anthony M. Magliocco, Don Morris, Alexander C. Klimowicz, T Ogilvie, EN Kornaga, RW Cartun, M Konno, Marc Webster
Publikováno v:
Cancer Research. 72:P1-07
Introduction: Adjuvant tamoxifen is the standard therapy for early stage hormone receptor+ breast cancers (BC). Estrogen receptor (ER) and progesterone receptor (PR) analysis is routinely performed by immunohistochemical (IHC) testing on BC specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5e6d7c6ba4c32340ba1a3e685e41e77
https://doi.org/10.1158/0008-5472.sabcs12-p1-07-10
https://doi.org/10.1158/0008-5472.sabcs12-p1-07-10
Autor:
Anthony M. Magliocco, Alexander C. Klimowicz, EN Kornaga, M Konno, Annie Yau, Stephanie K. Petrillo, B Pohorelic
Publikováno v:
Cancer Research. 71:P5-11
Background Adjuvant endocrine therapy reduces the risk of recurrence and death in hormone receptor positive breast cancer patients. However, 40–50% of estrogen receptor (ER) positive tumors are resistant to endocrine therapy. We have previously sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dce93bf181fccfcd1733b8d7964b58d3
https://doi.org/10.1158/0008-5472.sabcs11-p5-11-11
https://doi.org/10.1158/0008-5472.sabcs11-p5-11-11
Autor:
Sasha M. Lupichuk, Allan Andresson Lima Pereira, Sunil Verma, EN Kornaga, Adriana Reis Brandao Matutino
Publikováno v:
Journal of Clinical Oncology. 36:e18617-e18617
e18617Background: Insurance status affects cancer survival in the US. In the Canadian system, health care access is similar for the whole population. The purpose of this study was to compare clinic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3cfc508bf32cfa60f1fcaa789574bd2
https://doi.org/10.1200/jco.2018.36.15_suppl.e18617
https://doi.org/10.1200/jco.2018.36.15_suppl.e18617